Clinical Trial Update: The IVO-LUNG Study [Phase 2]

View source ↗

Summary

The IVO-LUNG Study is a Phase 2 clinical trial for Non-Small Cell Lung Cancer (Stage III) that is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non Small Cell Lung Cancer (Stage III) | Phase 2 | Status: NOT_YET_RECRUITING